Institution profile

神戸ハーバーランド免疫療法クリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 03E2103004 +3

Location

Prefecture
Hyogo
Address
神戸市中央区東川崎町1丁目3番3号 神戸ハーバーランドセンタービル14階

Plan classification

  • Class INot registered
  • Class IINot registered
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 神戸ハーバーランド免疫療法クリニック 認定再生医療等委員会

Public score

32.1/ 100

A · Review level
10.0 / 30
B · Technologies
18.5 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
0.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1519of 1736

Registered technologies
4
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 32.1
Public score →100

Registered technologies (4)

NK and immune cells 4
Registered technologies · Japanese originalTechnology areasPlan classification
悪性新生物の治療及び再発予防を目的にした樹状細胞ワクチン療法NK and immune cellsClass III
悪性新生物の治療及び再発予防を目的にした活性化Tリンパ球療法NK and immune cellsClass III
悪性新生物の治療及び再発予防を目的にしたナチュラルキラー細胞療法NK and immune cellsClass III
悪性新生物の治療及び再発予防を目的とする、樹状細胞を用いたNKT療法NK and immune cellsClass III

Certified committee for regenerative medicine

  • 神戸ハーバーランド免疫療法クリニック 認定再生医療等委員会

Public document number

  • 03E2103004
  • 03E2103005
  • 02E2511004
  • 02E2512017
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
悪性新生物の治療及び再発予防を目的にした活性化Tリンパ球療法Class III神戸ハーバーランド免疫療法クリニック 認定再生医療等委員会03E2103004
悪性新生物の治療及び再発予防を目的にしたナチュラルキラー細胞療法Class III神戸ハーバーランド免疫療法クリニック 認定再生医療等委員会03E2103005
悪性新生物の治療及び再発予防を目的にした樹状細胞ワクチン療法Class III神戸ハーバーランド免疫療法クリニック 認定再生医療等委員会02E2511004
悪性新生物の治療及び再発予防を目的とする、樹状細胞を用いたNKT療法Class III神戸ハーバーランド免疫療法クリニック 認定再生医療等委員会02E2512017

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor